Latest News

FDA approves first gene therapy for spinal muscular atrophy

(HealthDay)—The first gene therapy has been approved to treat children younger than 2 years with spinal muscular atrophy (SMA), the U.S. Food and Drug Administration announced Friday.

Source link




Related posts

AVITA Medical Announces Presentation of RECELL® System Effectiveness and Safety at Eastern Great Lakes Burn Conference

Newsemia

Optimism: The Secret To Longer Life?

Newsemia

Medical News Today: What is a normal body temperature range?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy